about
Crystal structure of the 28 kDa glutathione S-transferase from Schistosoma haematobiumProstaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathwaysActivation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouseActivation of the D prostanoid receptor 1 regulates immune and skin allergic responsesCytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatmentScavenger receptors in human airway epithelial cells: role in response to double-stranded RNAPivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion.Spleen-resident CD4+ and CD4- CD8α- dendritic cell subsets differ in their ability to prime invariant natural killer T lymphocytes.Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infectionColonic inflammation in mice is improved by cigarette smoke through iNKT cells recruitment.A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection.Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damagesRole of the D prostanoid receptor 1 in the modulation of immune and inflammatory responses.Schistosomes: the road from host-parasite interactions to vaccines in clinical trials.Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobiumActivation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cellsGalectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells.Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.Mechanisms of Invariant NKT Cell Activity in Restraining Bacillus anthracis Systemic Dissemination.[Influenza and secondary bacterial infections: threats and treatments].[iNKT cells: potential therapeutic targets to fight anthrax].Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.A type I IFN-dependent pathway induced by Schistosoma mansoni eggs in mouse myeloid dendritic cells generates an inflammatory signature.Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming.Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy.Key role for respiratory CD103(+) dendritic cells, IFN-γ, and IL-17 in protection against Streptococcus pneumoniae infection in response to α-galactosylceramide.Schistosome N-glycans containing core alpha 3-fucose and core beta 2-xylose epitopes are strong inducers of Th2 responses in mice.Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice.Notch signaling regulates follicular helper T cell differentiation.Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response.Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.Lung inflammation and thymic atrophy after bleomycin are controlled by the prostaglandin D2 receptor DP1.Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides.Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma.Role of marginal zone B lymphocytes in invariant NKT cell activation.
P50
Q27641897-10AD494D-9C74-48FA-A37E-26E4697744CAQ28188268-A82CA7A3-74DD-4E5F-BAD8-53AAADC60CCAQ28238317-5B5800B5-9936-41C6-9DB9-8637336DE3F1Q28248738-800F47E0-5D50-4B41-B9A7-FD0C7217C9B3Q28538582-691CFE20-5251-4811-A035-55054263549EQ31081134-704FA8AD-14A5-4A5D-A6D5-F6AF18C42350Q33972812-73BE7C4B-A584-48BF-8289-CC2B181EC724Q34069630-908EE149-3EC9-4559-8313-81A779ECB07BQ34228652-B856B0D1-8AB0-4E92-93ED-57030D126F95Q34431558-9530D04A-4685-4A6B-A427-23BE2424C1C9Q34701073-FEC42CFE-1170-4662-8D15-9F8126412CC9Q35235639-07AAD6EF-A4B4-41E7-8189-7736163C6462Q35783980-2BB82E77-60CD-46E2-BBFB-5F9DF281402FQ35841871-4579F42A-CF25-4421-8F10-5D3ECAA2F6FDQ36016737-B4C24D41-4E01-4BDB-8C44-CF46B4D3287FQ36056288-79BB323B-C081-4213-A68A-44347A637B21Q36057144-8554237C-7DEE-4F76-A94B-41604648F636Q36229711-879D71BE-ACEF-446E-B8C0-2C2EE593671AQ36313888-7E4915A9-B463-4E21-8DD1-37A460D12D60Q38584555-0BC6D006-22B7-4E06-A013-E79B0F7FA082Q38986327-237B4C1D-05F8-48A1-9F53-0AC1A34C5E4EQ39412754-B7CCBAE1-CA92-46AB-9D86-BB9F0A546119Q40160725-8F26FADB-3F8C-4748-BECD-714EB71DB91EQ40173247-9BCB4538-1B08-4C1D-80AB-89EC7660E36AQ40477924-5A331528-C874-475D-B5E7-620EDB362CD2Q40587016-25449ECA-05E3-442D-9BC8-983AB9E0A8FBQ40649514-6F2219C9-7C23-4A50-B241-CCDB6CEF6610Q41139823-8524F5DE-DB2F-4624-AD47-B3A21B1ADBE8Q42717336-5149EECF-E087-43D1-A676-49ED261B0615Q43525129-FDAB4A5C-5B17-491F-A6B6-60941ED40BFEQ44049986-FAD6B77B-DCBE-4F35-B15E-B421B7A1EBDCQ44192684-EBFDF1EA-61E1-4330-A56C-7BEC166483EEQ44432148-14342BF4-B889-4670-BD87-531BD9762EEAQ44467140-8C845D32-BA47-4D41-860B-66BE8D45C68DQ45367393-692FA0B7-A70C-4E53-A47A-BA44C69C2D3AQ45794277-13C1653B-646A-44A4-A366-7026D81770BAQ46155303-95D53FB9-4EEB-4DCA-A11F-E7647CF8B919Q46511194-0E306348-9F10-4871-9416-3DF641161DA3Q46820210-63517FB6-2F88-4825-8B07-AC7ED1E6A604Q47884480-2CACE976-A829-461F-98B8-3C1CC590661A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
François Trottein
@ast
François Trottein
@en
François Trottein
@es
François Trottein
@nl
type
label
François Trottein
@ast
François Trottein
@en
François Trottein
@es
François Trottein
@nl
prefLabel
François Trottein
@ast
François Trottein
@en
François Trottein
@es
François Trottein
@nl
P106
P21
P31
P496
0000-0003-3373-1814